-
2
-
-
78649673076
-
Hyponatremia in acute decompensated heart failure: Mechanisms, prognosis, and treatment options
-
G.T. Jao, and J.R. Chiong Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options Clin Cardiol 33 2010 666 671
-
(2010)
Clin Cardiol
, vol.33
, pp. 666-671
-
-
Jao, G.T.1
Chiong, J.R.2
-
3
-
-
33645901210
-
Hyponatremia and heart failure - Treatment considerations
-
D.A. Sica Hyponatremia and heart failure - treatment considerations Congest Heart Fail 12 2006 55 60
-
(2006)
Congest Heart Fail
, vol.12
, pp. 55-60
-
-
Sica, D.A.1
-
4
-
-
58949105072
-
Relation of serum sodium level to long-term outcome after a first hospitalization for heart failure with preserved ejection fraction
-
D. Rusinaru, O. Buiciuc, L. Leborgne, M. Slama, Z. Massy, and C. Tribouilloy Relation of serum sodium level to long-term outcome after a first hospitalization for heart failure with preserved ejection fraction Am J Cardiol 103 2009 405 410
-
(2009)
Am J Cardiol
, vol.103
, pp. 405-410
-
-
Rusinaru, D.1
Buiciuc, O.2
Leborgne, L.3
Slama, M.4
Massy, Z.5
Tribouilloy, C.6
-
5
-
-
34548348725
-
Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: An analysis from the OPTIMIZE-HF registry
-
M. Gheorghiade, W.T. Abraham, N.M. Albert, W. Gattis Stough, B.H. Greenberg, and C.M. O'Connor Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry Eur Heart J 28 2007 980 988
-
(2007)
Eur Heart J
, vol.28
, pp. 980-988
-
-
Gheorghiade, M.1
Abraham, W.T.2
Albert, N.M.3
Gattis Stough, W.4
Greenberg, B.H.5
O'Connor, C.M.6
-
6
-
-
35348978348
-
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial
-
M. Gheorghiade, J.S. Rossi, W. Cotts, D.D. Shin, A.S. Hellkamp, and I.L. Pina Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial Arch Intern Med 167 2007 1998 2005
-
(2007)
Arch Intern Med
, vol.167
, pp. 1998-2005
-
-
Gheorghiade, M.1
Rossi, J.S.2
Cotts, W.3
Shin, D.D.4
Hellkamp, A.S.5
Pina, I.L.6
-
7
-
-
84856394054
-
Impact of change in serum sodium concentration on mortality in patients hospitalized with heart failure and hyponatremia
-
V.D. Madan, E. Novak, and M.W. Rich Impact of change in serum sodium concentration on mortality in patients hospitalized with heart failure and hyponatremia Circ Heart Fail 4 2011 637 643
-
(2011)
Circ Heart Fail
, vol.4
, pp. 637-643
-
-
Madan, V.D.1
Novak, E.2
Rich, M.W.3
-
8
-
-
0033517302
-
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
-
B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
-
(1999)
N Engl J Med
, vol.341
, pp. 709-717
-
-
Pitt, B.1
Zannad, F.2
Remme, W.J.3
Cody, R.4
Castaigne, A.5
Perez, A.6
-
9
-
-
70449491019
-
Loop diuretics in acute decompensated heart failure: Necessary? Evil? A necessary evil?
-
G.M. Felker, C.M. O'Connor, and E. Braunwald Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ Heart Fail 2 2009 56 62
-
(2009)
Circ Heart Fail
, vol.2
, pp. 56-62
-
-
Felker, G.M.1
O'Connor, C.M.2
Braunwald, E.3
-
10
-
-
42149105187
-
Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review
-
S.G. Coca, R. Yalavarthy, J. Concato, and C.R. Parikh Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review Kidney Int 73 2008 1008 1016
-
(2008)
Kidney Int
, vol.73
, pp. 1008-1016
-
-
Coca, S.G.1
Yalavarthy, R.2
Concato, J.3
Parikh, C.R.4
-
11
-
-
18844423537
-
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study
-
L. Klein, C.M. O'Connor, J.D. Leimberger, W. Gattis-Stough, I.L. Pina, and G.M. Felker Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study Circulation 111 2005 2454 2460
-
(2005)
Circulation
, vol.111
, pp. 2454-2460
-
-
Klein, L.1
O'Connor, C.M.2
Leimberger, J.D.3
Gattis-Stough, W.4
Pina, I.L.5
Felker, G.M.6
-
12
-
-
0033584460
-
Hormones and hemodynamics in heart failure
-
R.W. Schrier, and W.T. Abraham Hormones and hemodynamics in heart failure N Engl J Med 341 1999 577 585
-
(1999)
N Engl J Med
, vol.341
, pp. 577-585
-
-
Schrier, R.W.1
Abraham, W.T.2
-
13
-
-
0025169729
-
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure
-
M.A. Fifer, C.R. Molina, A.C. Quiroz, T.D. Giles, H.C. Herrmann, and I.R. De Scheerder Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure Am J Cardiol 65 1990 211 216
-
(1990)
Am J Cardiol
, vol.65
, pp. 211-216
-
-
Fifer, M.A.1
Molina, C.R.2
Quiroz, A.C.3
Giles, T.D.4
Herrmann, H.C.5
De Scheerder, I.R.6
-
14
-
-
0029844772
-
Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure
-
T.P. Dormans, and P.G. Gerlag Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure Eur Heart J 17 1996 1867 1874
-
(1996)
Eur Heart J
, vol.17
, pp. 1867-1874
-
-
Dormans, T.P.1
Gerlag, P.G.2
-
15
-
-
0027083053
-
Clinical pharmacology of loop diuretics in health and disease
-
D.C. Brater Clinical pharmacology of loop diuretics in health and disease Eur Heart J 13 1992 10 14
-
(1992)
Eur Heart J
, vol.13
, pp. 10-14
-
-
Brater, D.C.1
-
16
-
-
0027285085
-
Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial
-
A.L. Gerbes, U. Bertheau-Reitha, C. Falkner, D. Jungst, and G. Paumgartner Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial J Hepatol 17 1993 353 358
-
(1993)
J Hepatol
, vol.17
, pp. 353-358
-
-
Gerbes, A.L.1
Bertheau-Reitha, U.2
Falkner, C.3
Jungst, D.4
Paumgartner, G.5
-
17
-
-
0023521927
-
Comparison of loop diuretics in patients with chronic renal insufficiency
-
J.R. Voelker, D. Cartwright-Brown, S. Anderson, J. Leinfelder, D.A. Sica, and J.P. Kokko Comparison of loop diuretics in patients with chronic renal insufficiency Kidney Int 32 1987 572 578
-
(1987)
Kidney Int
, vol.32
, pp. 572-578
-
-
Voelker, J.R.1
Cartwright-Brown, D.2
Anderson, S.3
Leinfelder, J.4
Sica, D.A.5
Kokko, J.P.6
-
18
-
-
77953593318
-
HFSA 2010 Comprehensive Heart Failure Practice Guideline
-
J. Lindenfeld, N.M. Albert, J.P. Boehmer, S.P. Collins, J.A. Ezekowitz, and M.M. Givertz HFSA 2010 Comprehensive Heart Failure Practice Guideline J Card Fail 16 2010 e1 e194
-
(2010)
J Card Fail
, vol.16
-
-
Lindenfeld, J.1
Albert, N.M.2
Boehmer, J.P.3
Collins, S.P.4
Ezekowitz, J.A.5
Givertz, M.M.6
-
19
-
-
34548813626
-
Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the ESCAPE trial
-
V. Hasselblad, W. Gattis Stough, M.R. Shah, Y. Lokhnygina, C.M. O'Connor, and R.M. Califf Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial Eur J Heart Fail 9 2007 1064 1069
-
(2007)
Eur J Heart Fail
, vol.9
, pp. 1064-1069
-
-
Hasselblad, V.1
Gattis Stough, W.2
Shah, M.R.3
Lokhnygina, Y.4
O'Connor, C.M.5
Califf, R.M.6
-
20
-
-
0033592418
-
Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction
-
H.A. Cooper, D.L. Dries, C.E. Davis, Y.L. Shen, and M.J. Domanski Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction Circulation 100 1999 1311 1315
-
(1999)
Circulation
, vol.100
, pp. 1311-1315
-
-
Cooper, H.A.1
Dries, D.L.2
Davis, C.E.3
Shen, Y.L.4
Domanski, M.J.5
-
21
-
-
0021161493
-
Clinical aspects and pathophysiology of diuretic-induced hyponatremia
-
M. Abramow, and E. Cogan Clinical aspects and pathophysiology of diuretic-induced hyponatremia Adv Nephrol Necker Hosp 13 1984 1 28
-
(1984)
Adv Nephrol Necker Hosp
, vol.13
, pp. 1-28
-
-
Abramow, M.1
Cogan, E.2
-
22
-
-
34249325160
-
Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction
-
J.E. Udelson, F.A. McGrew, E. Flores, H. Ibrahim, S. Katz, and G. Koshkarian Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction J Am Coll Cardiol 49 2007 2151 2159
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 2151-2159
-
-
Udelson, J.E.1
McGrew, F.A.2
Flores, E.3
Ibrahim, H.4
Katz, S.5
Koshkarian, G.6
-
23
-
-
33947713810
-
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial
-
M.A. Konstam, M. Gheorghiade, J.C. Burnett Jr., L. Grinfeld, A.P. Maggioni, and K. Swedberg Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 2007 1319 1331
-
(2007)
JAMA
, vol.297
, pp. 1319-1331
-
-
Konstam, M.A.1
Gheorghiade, M.2
Burnett, Jr.J.C.3
Grinfeld, L.4
Maggioni, A.P.5
Swedberg, K.6
|